DRESS syndrome secondary prevention: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
YazanDaaboul (talk | contribs) |
||
| Line 6: | Line 6: | ||
Secondary preventive measures to avoid DRESS syndrome include avoidance of drug re-exposure, screening for cross-reacting agents using ''in vitro'' lymphocyte toxicity assays, and possibly desensitization techniques. | Secondary preventive measures to avoid DRESS syndrome include avoidance of drug re-exposure, screening for cross-reacting agents using ''in vitro'' lymphocyte toxicity assays, and possibly desensitization techniques. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary preventive measures to avoid DRESS syndrome include the following: | Secondary preventive measures to avoid DRESS syndrome include the following:<ref name="pmid12771485">{{cite journal| author=Tas S, Simonart T| title=Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. | journal=Dermatology | year= 2003 | volume= 206 | issue= 4 | pages= 353-6 | pmid=12771485 | doi=69956 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12771485 }} </ref> | ||
*Avoid re-exposure to drugs that have previously caused DRESS syndrome | *Avoid re-exposure to drugs that have previously caused DRESS syndrome | ||
*Screen for cross-reacting agents using ''in vitro'' lymphocyte toxicity assays | *Screen for cross-reacting agents using ''in vitro'' lymphocyte toxicity assays | ||
*Desensitization has not been reported to be effective in some case reports, but the true effectiveness of the desensitization has not been studied.<ref name="pmid9761034">{{cite journal| author=Moreno-Ancillo A, López-Serrano MC| title=Hypersensitivity reactions to drugs in HIV-infected patients. Allergic evaluation and desensitization. | journal=Clin Exp Allergy | year= 1998 | volume= 28 Suppl 4 | issue= | pages= 57-60 | pmid=9761034 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9761034 }} </ref> | *Desensitization has not been reported to be effective in some case reports, but the true effectiveness of the desensitization has not been studied.<ref name="pmid9761034">{{cite journal| author=Moreno-Ancillo A, López-Serrano MC| title=Hypersensitivity reactions to drugs in HIV-infected patients. Allergic evaluation and desensitization. | journal=Clin Exp Allergy | year= 1998 | volume= 28 Suppl 4 | issue= | pages= 57-60 | pmid=9761034 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9761034 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:34, 21 September 2015
|
DRESS syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
DRESS syndrome On the Web |
|
American Roentgen Ray Society Images of DRESS syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
Overview
Secondary preventive measures to avoid DRESS syndrome include avoidance of drug re-exposure, screening for cross-reacting agents using in vitro lymphocyte toxicity assays, and possibly desensitization techniques.
Secondary Prevention
Secondary preventive measures to avoid DRESS syndrome include the following:[1]
- Avoid re-exposure to drugs that have previously caused DRESS syndrome
- Screen for cross-reacting agents using in vitro lymphocyte toxicity assays
- Desensitization has not been reported to be effective in some case reports, but the true effectiveness of the desensitization has not been studied.[2]
References
- ↑ Tas S, Simonart T (2003). "Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update". Dermatology. 206 (4): 353–6. doi:69956 Check
|doi=value (help). PMID 12771485. - ↑ Moreno-Ancillo A, López-Serrano MC (1998). "Hypersensitivity reactions to drugs in HIV-infected patients. Allergic evaluation and desensitization". Clin Exp Allergy. 28 Suppl 4: 57–60. PMID 9761034.